MHRA, Eucomed Agree Guidance Needed To Clarify Reclassification Process
This article was originally published in The Gray Sheet
Executive Summary
Guidance on the degree of evidence required for medical device reclassification will prevent friction of the type that arose between industry and regulators during European implant policymaking, MHRA's Steve Owen suggested June 24
You may also be interested in...
Mobile Bearing Knees Get FDA Panel Nod For Class II; J&J Sees Competition
Unicompartmental mobile bearing knees should be reclassified as Class II with special controls despite a lack of clinical safety data addressing implant wear and fracture, according to FDA's Orthopaedic & Rehabilitation Devices Panel
“Appropriate” Classification Should Be European Goal – MHRA Devices Head
The European device industry is urging national competent authorities to withhold their decisions on joint implant upclassification until additional data are ready for release next month
Cosmetic And Personal Care Trademark Review: 9 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.